RESISTANT PSYCHOSIS TREATED SUCCESSFULLY BY INDOKLON(1, 2, 3)
Abstract
A case is presented in which a patient's delusions, which had been resistant to ECT and tranquilizers, cleared up rapidly after only one Indoklon treatment. Indoklon, therefore, is an important somatic treatment in psychiatry because, although it is not yet generally available(6), it has distinct advantages: it is preferred over ECT by most patients(3), it does not require a long course of treatment or costly hospitalizations (3), it can be done as an outpatient or office procedure, it is safer than ECT(1, 2), and, as shown by this report, it is of dramatic benefit in some cases resistant to other forms of psychiatric treatment.
The cooperation of the Medical Research Foundation of Philadelphia in providing the Indoklon used in this study is gratefully acknowledged.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
